Ozempic (semaglutide) is a once-weekly injectable GLP-1 receptor agonist manufactured by Novo Nordisk, FDA-approved for type 2 diabetes and widely prescribed off-label for weight management. Like all GLP-1 medications, Ozempic carries a defined side effect profile that is well-characterized across multiple clinical trials involving thousands of patients. Most side effects are gastrointestinal, predictable, and manageable with proper dose escalation. Weight Method providers monitor every patient throughout treatment to catch and address side effects early, adjust dosing as needed, and ensure you stay on track safely.
Ozempic side effects include nausea (44%), diarrhea (30%), and vomiting (24%) based on FDA clinical trial data. Most side effects are mild to moderate and decrease over time. Weight Method prescribes Ozempic through licensed providers with ongoing medical monitoring.
Key Fact
The most common Ozempic side effects are gastrointestinal: nausea (44%), diarrhea (30%), vomiting (24%), and constipation (24%) in clinical trials. Most are mild-to-moderate and resolve within 4-8 weeks as the body adjusts to treatment.
Source: Ozempic FDA prescribing information
Nausea, diarrhea, vomiting, constipation, and abdominal pain are the most common Ozempic side effects, affecting 5-20% of patients and typically resolving within 2-4 weeks.
The most frequently reported side effects of Ozempic are nausea (affecting roughly 15-20% of patients), diarrhea (8-10%), vomiting (5-9%), constipation (5-7%), and abdominal pain (5-7%). These GI effects are most common during the first few weeks of treatment and immediately following dose increases, as your body adjusts to the medication's effect on gastric motility and appetite signaling. The majority of patients find these symptoms mild to moderate and self-limiting, typically resolving within days to two weeks at each dose level. Eating smaller meals, avoiding high-fat or greasy foods, and staying well-hydrated can meaningfully reduce GI discomfort during the adjustment period.
Rare but serious risks include pancreatitis, gallbladder disease, kidney injury, and thyroid tumors (boxed warning) — each occurring in less than 1% of clinical trial patients.
Ozempic carries a boxed warning for thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), based on findings in rodent studies; it is contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Rare but serious adverse events include acute pancreatitis (presenting as severe, persistent abdominal pain that may radiate to the back), gallbladder disease including cholelithiasis and cholecystitis, and acute kidney injury -- most often secondary to severe dehydration from vomiting or diarrhea. Hypoglycemia risk is low when Ozempic is used alone but increases when combined with insulin or sulfonylureas. Serious allergic reactions including anaphylaxis have been reported but are very rare.
Following the gradual dose-escalation schedule (0.25mg to 2mg), eating smaller low-fat meals, and staying well-hydrated significantly reduces gastrointestinal side effect severity.
Ozempic's dose-escalation protocol -- starting at 0.25mg and increasing through 0.5mg, 1mg, and up to 2mg over several months -- is specifically engineered to minimize GI side effects by allowing your body to adapt gradually. If nausea is bothersome, your Weight Method provider may recommend staying at a lower dose for an extra two to four weeks before escalating, a strategy shown to significantly reduce symptom severity. Practical tips include eating slowly, choosing bland foods during dose transitions, avoiding lying down immediately after meals, and drinking plenty of water throughout the day. Your provider is available between appointments to adjust your plan if side effects become uncomfortable or persistent.
Contact your doctor immediately for severe persistent abdominal pain, signs of allergic reaction, decreased urination, or a neck lump with hoarseness or difficulty swallowing.
Contact your Weight Method provider or seek immediate medical attention if you experience severe abdominal pain that does not go away (possible pancreatitis), signs of an allergic reaction such as swelling of the face, lips, or throat, difficulty breathing, or a rapid heartbeat. You should also reach out if you notice symptoms of gallbladder problems including persistent upper-right abdominal pain, fever, or jaundice, or signs of kidney issues such as significantly decreased urination or dark-colored urine. A lump or swelling in your neck, hoarseness, or difficulty swallowing could indicate a thyroid concern and should be evaluated promptly. When in doubt, always err on the side of contacting your care team.
Take our 2-minute quiz to see if you qualify for GLP-1 treatment.
Start QuizFree consultation. No commitment.